Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesothelioma.
Ye L, Ryu H, Granadier D, Nguyen LT, Simoni Y, Dick I, Firth T, Rouse E, Chiang P, Lee YCG, Robinson BW, Creaney J, Newell EW, Redwood AJ. Ye L, et al. Among authors: creaney j. Transl Lung Cancer Res. 2024 Sep 30;13(9):2352-2372. doi: 10.21037/tlcr-24-284. Epub 2024 Sep 27. Transl Lung Cancer Res. 2024. PMID: 39430319 Free PMC article.
New Markers for Management of Mesothelioma.
Nash A, Firth Née Phan T, Creaney J. Nash A, et al. Among authors: creaney j. Semin Respir Crit Care Med. 2023 Aug;44(4):491-501. doi: 10.1055/s-0043-1769097. Epub 2023 May 30. Semin Respir Crit Care Med. 2023. PMID: 37253383 Review.
Immune marker expression of irradiated mesothelioma cell lines.
Chang F, Keam S, Hoang TS, Creaney J, Gill S, Nowak AK, Ebert M, Cook AM. Chang F, et al. Among authors: creaney j. Front Oncol. 2022 Oct 31;12:1020493. doi: 10.3389/fonc.2022.1020493. eCollection 2022. Front Oncol. 2022. PMID: 36387076 Free PMC article.
Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.
Ramarao-Milne P, Kondrashova O, Patch AM, Nones K, Koufariotis LT, Newell F, Addala V, Lakis V, Holmes O, Leonard C, Wood S, Xu Q, Mukhopadhyay P, Naeini MM, Steinfort D, Williamson JP, Bint M, Pahoff C, Nguyen PT, Twaddell S, Arnold D, Grainge C, Basirzadeh F, Fielding D, Dalley AJ, Chittoory H, Simpson PT, Aoude LG, Bonazzi VF, Patel K, Barbour AP, Fennell DA, Robinson BW, Creaney J, Hollway G, Pearson JV, Waddell N. Ramarao-Milne P, et al. Among authors: creaney j. ESMO Open. 2022 Aug;7(4):100540. doi: 10.1016/j.esmoop.2022.100540. Epub 2022 Jul 15. ESMO Open. 2022. PMID: 35849877 Free PMC article.
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.
Creaney J, Patch AM, Addala V, Sneddon SA, Nones K, Dick IM, Lee YCG, Newell F, Rouse EJ, Naeini MM, Kondrashova O, Lakis V, Nakas A, Waller D, Sharkey A, Mukhopadhyay P, Kazakoff SH, Koufariotis LT, Davidson AL, Ramarao-Milne P, Holmes O, Xu Q, Leonard C, Wood S, Grimmond SM, Bueno R, Fennell DA, Pearson JV, Robinson BW, Waddell N. Creaney J, et al. Genome Med. 2022 May 30;14(1):58. doi: 10.1186/s13073-022-01060-8. Genome Med. 2022. PMID: 35637530 Free PMC article.
BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study.
Louw A, Panou V, Szejniuk WM, Meristoudis C, Chai SM, van Vliet C, Lee YCG, Dick IM, Firth T, Lynggaard LA, Asghari AB, Vyberg M, Hansen J, Creaney J, Røe OD. Louw A, et al. Among authors: creaney j. J Thorac Oncol. 2022 Jul;17(7):921-930. doi: 10.1016/j.jtho.2022.04.008. Epub 2022 Apr 27. J Thorac Oncol. 2022. PMID: 35489694 Free article.
153 results